Form 8-K · Current report
Xylem Inc. 8-K, filed Aug 13, 2026
- Filed
- CIK
- 0001524472
- Accession no.
- 0001524472-26-000119
Summary
Xylem Inc. expanded its board of directors from nine to ten members and appointed D. Christian Koch, board chair, president and CEO of Carlisle Companies, as a director effective August 13, 2026. Koch, whom the board determined is independent, was also named to the board's Leadership Development and Compensation Committee and Nominating and Governance Committee.
Key points
- Koch serves as Board Chair, President and Chief Executive Officer of Carlisle Companies Incorporated, which has roughly $5 billion in annual revenue.
- Koch holds an MBA from the University of Minnesota and a bachelor's degree from Macalester College.
- Koch will receive standard non-employee director compensation, prorated for the current term.
- Xylem board chair Robert Friel and CEO Matthew Pine both welcomed the appointment.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On August 13, 2026, the Board of Directors (the “Board”) of the Company increased the size of the Board from 9 to 10 directors and appointed D. Christian Koch as a member of the Board to fill the vacancy, effective immediately. The Board also appointed Mr. Koch as a member of the Leadership Development and Compensation Committee and the Nominating and Governance Committee, effective immediately. The Board has determined that Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.